IL-27 improves migrational and antiviral potential of CB dendritic cells

Human Immunology

Volumn 75, Issue 6, 2014, Pages 584-591

  Birkholz, Julia ^a   Doganci, Aysefa ^a   Darstein, Claudia ^a   Gehring, Stephan ^a   Zepp, Fred ^a   Meyer, Claudius U ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 27; INTERLEUKIN 8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRF8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCR1 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; IL27 PROTEIN, HUMAN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN DERIVATIVE; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORD BLOOD DENDRITIC CELL; DENDRITIC CELL; GENE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MONOCYTE; NEWBORN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ADULT; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; DENDRITIC CELLS; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; INTERFERON REGULATORY FACTORS; INTERLEUKIN-8; INTERLEUKINS; MONOCYTES; RECEPTORS, CCR1; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900519238     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.02.004     Document Type: Article

References (47)

1. Langrish C.L., Buddle J.C., Thrasher A.J., Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002, 128:118-123.
2. Naderi N., Pourfathollah A.A., Alimoghaddam K., Moazzeni S.M. Cord blood dendritic cells prevent the differentiation of naive T-helper cells towards Th1 irrespective of their subtype. Clin Exp Med 2009, 9:29-36.
3. Goriely S., Vincart B., Stordeur P., Vekemans J., Willems F., Goldman M., et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001, 166:2141-2146.
4. Krumbiegel D., Anthogalidis-Voss C., Markus H., Zepp F., Meyer C.U. Enhanced expression of IL-27 mRNA in human newborns. Pediatr Allergy Immunol 2008, 19:513-516.
5. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
6. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004, 172:2225-2231.
7. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 2005, 175:2191-2200.
8. Guzzo C., Ayer A., Basta S., Banfield B.W., Gee K. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J Immunol 2012, 188:864-873.
9. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007, 8:1380-1389.
10. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936.
11. Doganci A., Birkholz J., Gehring S., Puhl A.G., Zepp F., Meyer C.U. In the presence of IL-21 human cord blood T cells differentiate to IL-10 producing Th1 but not Th17 or Th2 cells. Int Immunol 2012, 25:157-169.
12. Dauer M., Obermaier B., Herten J., Haerle C., Pohl K., Rothenfusser S., et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 2003, 170:4069-4076.
13. Zhang J., Qian X., Ning H., Yang J., Xiong H., Liu J. Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. J Biol Chem 2010, 285:21269-21281.
14. Honda K., Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006, 6:644-658.
15. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the hla system. Hum Immunol 2004, 66(2005):571-636.
16. Kropshofer H., Vogt A.B., Thery C., Armandola E.A., Li B.C., Moldenhauer G., et al. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 1998, 17:2971-2981.
17. Kropshofer H., Hammerling G.J., Vogt A.B. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol Rev 1999, 172:267-278.
18. Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., et al. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunological reviews 2005, 207:242-260.
19. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011, 1:519-525.
20. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 2013, 13:46-57.
21. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996, 184:747-752.
22. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969.
23. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev 2005, 16:581-592.
24. Van Damme J., Proost P., Lenaerts J.P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992, 176:59-65.
25. Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., Moser B. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 1994, 8:1055-1060.
26. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
27. Kraft J.D., Horzempa J., Davis C., Jung J.Y., Pena M.M., Robinson C.M. Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses. Immunology 2013, 139:484-493.
28. Contursi C., Wang I.M., Gabriele L., Gadina M., O'Shea J., Morse H.C., et al. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci USA 2000, 97:91-96.
29. Scharton-Kersten T., Contursi C., Masumi A., Sher A., Ozato K. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med 1997, 186:1523-1534.
30. Giese N.A., Gabriele L., Doherty T.M., Klinman D.M., Tadesse-Heath L., Contursi C., et al. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med 1997, 186:1535-1546.
31. Wang I.M., Contursi C., Masumi A., Ma X., Trinchieri G., Ozato K. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol 2000, 165:271-279.
32. Marquis J.F., Kapoustina O., Langlais D., Ruddy R., Dufour C.R., Kim B.H., et al. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet 2011, 7:e1002097.
33. Guo J., Peters K.L., Sen G.C. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 2000, 267:209-219.
34. Schmeisser H., Mejido J., Balinsky C.A., Morrow A.N., Clark C.R., Zhao T., et al. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J Virol 2010, 84:10671-10680.
35. Fensterl V., Sen G.C. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 2011, 31:71-78.
36. de Groot R., van Beelen A.J., Bakdash G., Taanman-Kueter E.W., de Jong E.C., Kapsenberg M.L. Viral dsRNA-activated human dendritic cells produce IL-27, which selectively promotes cytotoxicity in naive CD8+ T cells. J Leukoc Biol 2012.
37. Loetscher M., Loetscher P., Brass N., Meese E., Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol 1998, 28:3696-3705.
38. Kanda N., Shimizu T., Tada Y., Watanabe S. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 2007, 37:338-350.
39. Liu M., Guo S., Hibbert J.M., Jain V., Singh N., Wilson N.O., et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011, 22:121-130.
40. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998, 19:568-574.
41. Vasquez R.E., Xin L., Soong L. Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Inf Immun 2008, 76:161-169.
42. Shibata S., Tada Y., Kanda N., Nashiro K., Kamata M., Karakawa M., et al. Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 2010, 130:1034-1039.
43. Wittmann M., Zeitvogel J., Wang D., Werfel T. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 2009, 124:81-89.
44. Fujiwara S., Nagai H., Oniki S., Yoshimoto T., Nishigori C. Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-alpha-mediated chemokine production in human keratinocytes. Exp Dermatol 2012, 21:70-72.
45. Gong X., Gong W., Kuhns D.B., Ben-Baruch A., Howard O.M., Wang J.M. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 1997, 272:11682-11685.
46. de la Rosa G., Longo N., Rodriguez-Fernandez J.L., Puig-Kroger A., Pineda A., Corbi A.L., et al. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol 2003, 73:639-649.
47. Guzzo C., Che Mat N.F., Gee K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem 2010, 285:24404-24411.